Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment

Overview of attention for article published in International Journal of Nanomedicine, March 2017

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 57 Dimensions

Readers on

mendeley: 57 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 57 publications that cite this research output.

57

The most recent citing publications are shown below. View all 57 publications that cite this research output on Dimensions.

A self-targeting MOFs nanoplatform for treating metastatic triple-negative breast cancer through tumor microenvironment remodeling and chemotherapy potentiation

Article in International Journal of Pharmaceutics (August 2024)

Microfluidic chip for synergic drugs assay in 3D breast cancer cell

Article in Microfluidics and Nanofluidics (April 2024)

An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism

Article in Expert Opinion on Drug Delivery (February 2024)